K240554 is an FDA 510(k) clearance for the InferRead Lung CT.AI. Classified as Lung Computed Tomography System, Computer-aided Detection (product code OEB), Class II - Special Controls.
Submitted by Infervision Medical Technology Co., Ltd. (Beijing, CN). The FDA issued a Cleared decision on May 16, 2025 after a review of 443 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Radiology submissions.
View all Infervision Medical Technology Co., Ltd. devices